Agilent receives european ivdr class c certification for genetisure dx postnatal assay

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) today announced that its genetisure dx postnatal assay has received european ivdr class c certification. this certification demonstrates that the assay meets the higher standards established by ivdr. it ensures the continued availability of this trusted qualitative assay to clinical geneticists and other healthcare professionals throughout the eu. in vitro diagnostic devices, which include pregnancy tests, covid-19 tests,.
A Ratings Summary
A Quant Ranking